Speaker(s): 

J. Marc Simard, MD, PhD, University of Maryland - has nothing to disclose.

Learning Objectives: 

• 1 – Explain the role of SUR1-TRPM4 in brain swelling

  2 – Discuss an important update on the outcome of CHARM, the Phase 3 trial of IV glyburide in large hemispheric infarction

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Edward Monaco III, MD, PhD, Michel Lacroix, MD, Christopher Berry, DMSc, PA-C and Maurissa Cropf, RN have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session

None.